Author: Crisitiana Correia

At Curapath, we are committed to pushing the boundaries of polymer and lipid-based drug delivery. Today, we are excited to share that we have entered into a co-exclusive license agreement with Cristal Therapeutics to integrate their groundbreaking CliCr® bioconjugation platform into our technology and service portfolio. CliCr® provides a powerful,

Curapath is proud to announce the renewal of its Crédit Impôt Recherche (CIR)accreditation up to 2027. Granted by the French Ministry of Higher Education and Research, this accreditationallows French companies collaborating with Curapath to continue benefiting from theR&D tax credit on eligible research and development expenditures.The Crédit Impôt Recherche program

Curapath, a leading innovator in the design and manufacturing of polymer and lipid-based drug delivery systems, is proud to announce a strategic partnership with Iris Biotech, a global distributor of specialty reagents for drug development and delivery. Through this collaboration, Iris Biotech will offer a broad selection of Curapath’s proprietary